Japan IP Court reviews Kowa's glaucoma drug, packaging patent after JPO invalidation ruling
Japan’s Intellectual Property High Court is reviewing an appeal by Kowa Company after the country’s patent office invalidated most of its patent claims covering the glaucoma drug Granatec, siding with a...To view the full article, register now.
Already a subscriber? Click here to view full article